Shaaban A Elwan
Al Minyā, Egypt
NCT Number: NCT02009072
Pterygium is a common ocular pathology facing ophthalmologists that has varied surgical management techniques and high rate of post-operative recurrence. The investigators aim was to compare and evaluate the safety and efficacy outcomes of those two surgical procedures in management of primary pterygium.
Looking for future studies?
Notify Me24 year–74 year
All sexes
Interventional
Not applicable
Al Minyā, Egypt
Design: Prospective randomized clinical trial comparative study. Setting: Department of ophthalmology, Al-Minia University Faculty of medicine, Egypt.
Methods: The study included 150 eyes of 150 patients of primary pterygium. Twenty four to 74 years of age (mean 49 ± 12 years). Simple excision under local anesthesia was performed then closure of the bare sclera by sutureless and glue free conjunctival autograft in 50 eyes of 50 patients (group 1), versus sutured free conjunctival autograft in 100 eyes of 100 patients (group 2).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients complaining of primary pterygium with eye redness. Patients with pterygium threatening the visual axis.
Exclusion criteria
All cases not completed the follow up period for two years. Atrophic pterygium, pseudopterygium or double head pterygium.
Simple pterygium excision under local anesthesia was performed then closure of the bare sclera by sutureless and glue free conjunctival autograft in 50 eyes of 50 patients (group 1)
Other names: Sutureless and glue free LCAG
Simple pterygium excision under local anesthesia was performed then closure of the bare sclera by sutured limbal conjunctival autograft in 100 eyes of 100 patients (group 2).
Other names: Sutured LCAG
Time frame: 24 months
The main postoperative primary outcomes measure the recurrence rate which was defined as fibrovascular proliferation invading the cornea more than 1.5 mm at the site of previously excised pterygium.
Time frame: Third postoperative day,then weekly for one month
The secondary outcomes measure, postoperative pain, foreign body sensation, photophobia, hyperemia and chemosis.
Time frame: Third post-operative week
Overall satisfaction with the procedure 3 weeks post-operatively was recorded as four grades 0= unsatisfied, 1= low satisfaction, 2= moderate satisfaction and 3= highly satisfied, the data were collected as mean scores and recorded. The two groups were compared for overall satisfaction.
Time frame: 24 months
Complications was recorded including, persistent epithelial defect, dellen, inclusion cyst, pyogenic granuloma, conjunctival edema, corneal scleral necrosis, infective scleritis, keratitis and endophthalmitis.
Time frame: Intraoperative
Calculation of operative time for each patient procedure
Time frame: First post-operative month
Gain in uncorrected visual acuity (UCVA) for each patient from the base line measurement
Shaaban Elwan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05794204
Conjunctival Diseases, Eye Diseases
Glendale, California, United States
View Trial DetailsNCT05978687
Conjunctival Diseases, Eye Diseases
Brussels, Brussels Capital, Belgium
View Trial DetailsNCT06944132
Conjunctival Diseases, Corneal Diseases
Cairo, Egypt
View Trial DetailsNCT05627947
Conjunctival Diseases, Eye Diseases
Shibīn al Kawm, Egypt
View Trial Details